Clinical trial

Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma

NCT06057051

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2023-09-01

PhaseNA

Study timeline

Study start (actual)2023-09-01Date precision: day

Registry last updated2023-09-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Glaucomaunresolved

Interventions

iStent InfiniteDEVICE

Sponsors & collaborators

Glaukos Corporationlead sponsor

Mapped research locations

CincinnatiOhio, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06057051 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.